Total Payments
$9,465
2024 Payments
$858.25
Companies
43
Transactions
495
Medicare Patients
22,211
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$9,309 (98.4%)
Education$155.33 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,309 | 487 | 98.4% |
| Education | $155.33 | 8 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,386 | 89 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $909.97 | 55 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $788.32 | 44 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $673.72 | 37 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $605.55 | 34 | $0 (2022) |
| Amarin Pharma Inc. | $575.31 | 14 | $0 (2023) |
| Allergan, Inc. | $559.96 | 30 | $0 (2020) |
| Lilly USA, LLC | $361.22 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $357.43 | 20 | $0 (2024) |
| Esperion Therapeutics, Inc. | $353.18 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $858.25 | 35 | Boehringer Ingelheim Pharmaceuticals, Inc. ($134.70) |
| 2023 | $491.10 | 23 | Boehringer Ingelheim Pharmaceuticals, Inc. ($129.44) |
| 2022 | $588.13 | 31 | Esperion Therapeutics, Inc. ($116.63) |
| 2021 | $1,285 | 52 | Daiichi Sankyo Inc. ($179.58) |
| 2020 | $454.98 | 24 | BIODELIVERY SCIENCES INTERNATIONAL, INC. ($51.50) |
| 2019 | $1,205 | 55 | Amarin Pharma Inc. ($319.59) |
| 2018 | $2,396 | 131 | Novo Nordisk Inc ($679.87) |
| 2017 | $2,186 | 144 | Allergan Inc. ($380.31) |
All Payment Transactions
495 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Diabetes Care | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.78 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Diabetes | ||||||
| 10/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.69 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Education | In-kind items and services | $10.17 | General |
| Category: DIABETES | ||||||
| 08/30/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/28/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Obesity | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Cardiology | ||||||
| 08/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: PAIN | ||||||
| 07/09/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $29.58 | General |
| Category: Neurology | ||||||
| 06/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: DIABETES | ||||||
| 06/11/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Neurology | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Respiratory | ||||||
| 06/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Cardio-renal | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $43.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: Diabetes | ||||||
| 04/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: PSYCHIATRY | ||||||
| 04/24/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $120.39 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 52 | 7,126 | 9,403 | $1.1M | $428,077 |
| 2022 | 56 | 7,439 | 9,848 | $1.2M | $472,628 |
| 2021 | 58 | 6,660 | 8,525 | $1.0M | $432,447 |
| 2020 | 21 | 986 | 1,440 | $156,875 | $87,446 |
Total Patients
22,211
Total Services
29,216
Medicare Billing
$1.4M
Procedure Codes
187
All Medicare Procedures & Services
187 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 573 | 1,112 | $250,200 | $104,366 | 41.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 424 | 1,113 | $155,820 | $78,456 | 50.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 352 | 352 | $52,800 | $49,265 | 93.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 308 | 575 | $100,625 | $40,798 | 40.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 100 | 120 | $53,800 | $13,209 | 24.6% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 51 | 51 | $17,850 | $11,907 | 66.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 146 | 153 | $12,730 | $11,342 | 89.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 289 | 307 | $21,490 | $8,906 | 41.4% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 297 | 297 | $13,360 | $8,151 | 61.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 43 | 43 | $21,070 | $7,133 | 33.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 79 | 80 | $24,000 | $6,703 | 27.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 295 | 295 | $22,090 | $6,070 | 27.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 23 | 25 | $8,125 | $5,793 | 71.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 309 | 346 | $25,950 | $5,695 | 21.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 149 | 156 | $5,460 | $5,115 | 93.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 310 | 387 | $29,025 | $5,077 | 17.5% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 47 | 47 | $8,225 | $4,933 | 60.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 348 | 570 | $14,250 | $4,788 | 33.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 35 | 35 | $5,250 | $4,578 | 87.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $10,800 | $4,120 | 38.2% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 16 | 16 | $4,320 | $4,045 | 93.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 287 | 341 | $22,165 | $3,246 | 14.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 260 | 278 | $31,910 | $3,092 | 9.7% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 157 | 181 | $10,860 | $3,005 | 27.7% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 155 | 164 | $15,580 | $2,955 | 19.0% |
About Dr. Stephen Nguyen, MD
Dr. Stephen Nguyen, MD is a Internal Medicine healthcare provider based in Sun City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619976644.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Nguyen, MD has received a total of $9,465 in payments from pharmaceutical and medical device companies, with $858.25 received in 2024. These payments were reported across 495 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($9,309).
As a Medicare-enrolled provider, Nguyen has provided services to 22,211 Medicare beneficiaries, totaling 29,216 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 187 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Sun City, CA
- Active Since 07/20/2005
- Last Updated 07/09/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619976644
Products in Payments
- XARELTO (Drug) $770.96
- Vascepa (Drug) $575.31
- JARDIANCE (Drug) $489.21
- Tresiba (Drug) $442.89
- FARXIGA (Drug) $432.22
- Ozempic (Drug) $344.90
- TOUJEO (Drug) $324.86
- ENTRESTO (Drug) $310.16
- Victoza (Drug) $292.14
- NEXLETOL (Drug) $232.82
- TRADJENTA (Drug) $206.34
- ELIQUIS (Drug) $196.61
- VIBERZI (Drug) $189.92
- Enhertu (Drug) $179.58
- MYRBETRIQ (Drug) $161.81
- BYSTOLIC (Drug) $155.49
- SOLIQUA 100/33 (Drug) $141.82
- INVOKANA (Drug) $132.99
- BREZTRI (Drug) $131.14
- Aimovig (Biological) $122.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sun City
Richard Lam, Md, MD
Internal Medicine — Payments: $16,393
Internal Medicine $16,393
Dr. Rajesh Bhakta, M.d, M.D
Internal Medicine — Payments: $15,364
Internal Medicine $15,364
Dr. Keng-Yu Chuang, M.d, M.D
Internal Medicine — Payments: $15,021
Internal Medicine $15,021
Dr. Randall Piette, M.d, M.D
Internal Medicine — Payments: $11,833
Internal Medicine $11,833
Dr. Michael Johnson, M.d, M.D
Internal Medicine — Payments: $10,961
Internal Medicine $10,961
Srinivasa Palnati, Md, MD
Internal Medicine — Payments: $8,800
Internal Medicine $8,800